Aflofarm, the leader of on the OTC drug market in Poland, introduces a product novelty - Melabiorytm, a drug indicated as an excipient in cases of sleep disorders associated with changing time zones.

Thanks to its melatonin content (5 mg in one tablet), the product facilitates regulation of the daily rhythm of sleep and wakefulness in blind patients. Melabiorytm is also recommended for travelers who may experience sleep disorders due to time zone changes or shift workers who may also experience such problems.